Slate Pharmaceuticals Company
Slate Pharmaceuticals acquires, develops, and commercializes products for the diseases of maturing men and women.
Total Funding:
$9 777 000
Headquarters:
Durham, North Carolina, United States
Estimated Revenue:
$100M to $500M
Last Funding Type:
Debt Financing
Technology:
Physical Rehabilitation
Last Funding Date:
2010-09-24
Founded Date:
2007-01-01
Industry:
Longevity